Financial Information

This section of the COMPANY NAME InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing. 

Please note:  All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes.  COMPANY NAME assumes no responsibility for the accuracy of this data and provides it for informational purposes only.

NASDAQNUVL
Beta1.37
Shares Outstanding62.6M
Average Volume (10 days)419.8K
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)($2.03)
Sales (TTM)--
Book Value (MRQ)$6.32
Cash Flow (TTM)($1.39)
Cash (MRQ)$7.24

Analyst Views

Current Mean RecommendationStrong Buy
Strong Buy7
 
Buy0
 
Hold1
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Darlene Noci
Chief Development Officer
33,300
Acquire
Jan 5, 2024
Darlene Noci
Chief Development Officer
47,500
Acquire
Jan 5, 2024
James Richard Porter
President And CEO
112,800
Acquire
Jan 5, 2024
Darlene Noci
33,300
Acquire
Jan 5, 2024
Christopher Durant Turner
Chief Medical Officer
47,500
Acquire
Jan 5, 2024

Recent SEC Filings

Amended >= 5% Acquisition
Feb 14, 2024
Amended >= 5% Acquisition
Feb 14, 2024
>= 5% Acquisition
Feb 13, 2024
Amended >= 5% Acquisition
Feb 12, 2024
Amended >= 5% Acquisition
Feb 9, 2024